Retinal venous pressure in the non-affected eye of patients with retinal vein occlusions

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 10, 2014, Pages 1569-1571

  Mozaffarieh, Maneli ^a   Bartschi M ^a   Henrich, P B ^a   Schoetzau, A ^a   Flammer, J ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Central retinal vein occlusion; Retinal venous pressure; Unaffected contralateral eye

Indexed keywords

EID: 84896587879     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2617-3     Document Type: Article

References (21)

1. Napal Lecumberri JJ, Sedano Balbas C, Canal Villanueva J, Hernandez Hernandez JL (2013) Thrombophilia and vascular risk factors in retinal vein occlusion. Rev Clin Esp 213(5):229–234 (article in English/Spanish)
2. Zhou JQ, Xu L, Wang S, Wang YX, You QS, Tu Y et al (2013) The 10-year incidence and risk factors of retinal vein occlusion: the Beijing Eye Study. Ophthalmology 120(4):803–808
3. Lee JY, Yoon YH, Kim HK, Yoon HS, Kang SW, Kim JG et al (2013) Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group. J Korean Med Sci 28(1):136–144
4. Giannaki K, Politou M, Rouvas A, Merkouri E, Travlou A, Theodosiadis P et al (2013) Retinal vein occlusion: genetic predisposition and systemic risk factors. Blood Coagul Fibrinolysis 24(3):279–283
5. McAllister IL, Vijayasekaran S, Yu DY (2013) Intravitreal Tenecteplase (metalyse) (TNK) for acute management of retinal vein occlusions. Invest Ophthalmol Vis Sci 54(7):4910–4918
6. Kadonosono K, Yamane S, Arakawa A, Inoue M, Yamakawa T, Uchio E et al (2013) Endovascular cannulation with a microneedle for central retinal vein occlusion. JAMA Ophthalmol 131(6):783–786
7. Matonti F, Meyer F, Guigou S, Barthelemy T, Dumas S, Gobert F et al (2013) Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice. Acta Ophthalmol 91(7):e584–e586
8. Lu Y, Su L, Xu X (2013) Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ocul Pharmacol Ther 29(8):702–708
9. Huang P, Niu W, Ni Z, Wang R, Sun X (2013) A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusion. PLoS One 8(12):e82454
10. Rehak M, Tilgner E, Franke A, Rauscher FG, Brosteanu O, Wiedemann P (2013) Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefes Arch Clin Exp Ophthalmol [Epub ahead of print]
11. Fraenkl SA, Mozaffarieh M, Flammer J (2010) Retinal vein occlusions: the potential impact of a dysregulation of the retinal veins. EPMA J 1(2):253–261
12. Flammer J, Konieczka K, Flammer AJ (2013) The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J 4(1):14
13. Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S (2013) The eye and the heart. Eur Heart J 34(17):1270–1278
14. Jonas JB (2003) Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion. Graefes Arch Clin Exp Ophthalmol 241(5):367–370
15. Morgan WH, Cringle SJ, Kang MH, Pandav S, Balaratnasingam C, Ezekial D et al (2010) Optimizing the calibration and interpretation of dynamic ocular force measurements. Graefes Arch Clin Exp Ophthalmol 248(3):401–407
16. Jonas JB, Harder B (2007) Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion. Am J Ophthalmol 143(1):112–116
17. Haufschild T, Prunte C, Messerli J, Flammer J (2004) Increased endothelin-1 plasma level in young adults with retinal vascular occlusive diseases. Klin Monatsbl Augenheilkd 221(5):357–359
18. Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR (1998) Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol 82(5):498–503
19. Faraco G, Moraga A, Moore J, Anrather J, Pickel VM, Iadecola C (2013) Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation. Hypertension 62(4):759–766
20. Tsui JC, Shi-Wen X (2011) Endothelin-1 in peripheral arterial disease: a potential role in muscle damage. Pharmacol Res 63(6):473–476
21. Friedman JK, Nitta CH, Henderson KM, Codianni SJ, Sanchez L, Ramiro-Diaz JM et al (2014) Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity. Vasc Pharmacol 60(1):17–24